Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 25, 2026
Why Is Arm Holdings (ARM) Stock Up +10% Today?

Why Is Arm Holdings (ARM) Stock Up +10% Today?

Key Takeaways

  • ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135
  • The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model
  • Meta Platforms was confirmed as the first major customer for Arm's inaugural in-house AGI CPU chip, delivering a massive institutional endorsement
  • Arm unveiled an ambitious five-year revenue plan targeting $25 billion in annual sales, roughly a 5x increase from current levels, fundamentally reshaping the company's valuation narrative
  • Raymond James upgraded ARM to Outperform with a $166 price target, citing the company's "industry-leading bandwidth" in its new AGI CPU chip relative to x86-based rivals
  • Traders are watching whether ARM can sustain above the critical $150 psychological resistance level, and monitoring early progress toward the company's ambitious revenue targets

Opening Summary

Arm Holdings plc (ARM) is a Cambridge-based semiconductor and software design company that licenses processor architectures and instruction sets to the world's leading chipmakers — including Apple, Qualcomm, and Samsung — and whose CPU designs power the vast majority of the world's smartphones, tablets, and increasingly, data centers. On March 25, 2026, ARM shares surged approximately +10% in premarket trading, moving from a prior session close of roughly $135 to a premarket level of $148.6. The move was triggered by a landmark corporate announcement: Arm is officially entering the chip-manufacturing business with its first in-house designed AGI CPU, marking a fundamental transformation of the company's business model that stunned Wall Street and drew an immediate round of analyst upgrades.

Historic Business Model Pivot

For decades, Arm operated as the semiconductor industry's "neutral architect" — a company that designed and licensed processor blueprints to clients without ever competing directly in finished silicon. That era is now over. At a high-profile event in San Francisco, Arm confirmed it is launching its first self-developed AGI CPU chip, ending its tradition of exclusively selling intellectual property. The chip is engineered for the data center market, boasting up to 136 cores at a power draw of just 300 watts, and will be manufactured by TSMC, the world's leading foundry. This vertical integration gives Arm capabilities that no pure-licensing firm can match, allowing it to optimize performance across the entire stack for demanding AI workloads.

Meta Platforms Endorsement

The credibility of Arm's chip ambitions received an immediate institutional stamp of approval: Meta Platforms was confirmed as the launch customer for the new AGI CPU. For Meta, adopting Arm's self-designed chips offers meaningful reductions in data center operational costs — a key priority for hyperscalers racing to scale AI infrastructure. For Arm, the Meta endorsement signals to the broader market that its new chip can compete at the highest tier of enterprise silicon requirements, reducing the skepticism that often surrounds first-generation in-house designs.

The $25 Billion Revenue Blueprint

The market reaction was amplified by the scale of Arm's disclosed financial targets. The company projects its new chip business alone will generate approximately $15 billion in annual sales within five years. Combined with existing licensing operations, Arm's dual-engine strategy targets $25 billion in total annual revenue over the same period — representing roughly a 5x revenue increase from current levels. This projection fundamentally changes how analysts must model the stock. Rather than a predictable, slow-growing royalty collector, Arm is repositioning itself as a high-growth AI hardware company, a shift that warrants a meaningfully different earnings multiple.

Analyst Upgrades

The announcement immediately triggered analyst action. Raymond James upgraded ARM from Market Perform to Outperform and established a price target of $166, representing a roughly 23% premium to recent pre-announcement trading levels. The firm highlighted that Arm's AGI CPU chip delivers industry-leading bandwidth per rack versus traditional x86 CPUs, a performance characteristic critical for modern AI inference workloads. Earlier in March, HSBC had already upgraded ARM from Reduce to Buy with a price target of $205, citing structural undervaluation in Arm's AI transition. The confluence of multiple major bank upgrades added fuel to the premarket rally.

Market Context and Trading Activity

The premarket surge in ARM came with notably elevated volume, consistent with an institutional reallocation event rather than retail-driven momentum. Broader semiconductor sector ETFs, including the SOXX, were monitoring the move closely given Arm's foundational role across the chip ecosystem. The news arrives against a backdrop of continued AI infrastructure investment by hyperscalers, providing a favorable macro tailwind. Technically, the $150 level represents a critical psychological and chart-based resistance zone; a sustained close above that level would confirm a bullish breakout pattern and potentially open the path to the $160–$180 range referenced by multiple analysts. Importantly, ARM recently reported Q3 fiscal 2026 earnings with revenue growing 26% year-over-year to $1.24 billion, including data center royalty revenue that more than doubled — providing the fundamental foundation for today's strategic acceleration.

Trending AI Robots

For traders looking to capitalize on volatile, momentum-driven moves like today's ARM surge, Tickeron's Trending AI Robots page offers a curated selection of the platform's strongest-performing automated trading bots. While Tickeron hosts hundreds of AI-powered bots covering thousands of tickers across equities, ETFs, and crypto, the Trending AI Robots section surfaces only those bots demonstrating the strongest real-time performance under current market conditions. Bots on the platform vary by trading strategy, holding timeframe, risk profile, performance metrics, and the specific symbols they trade — offering tailored options for day traders, swing traders, and longer-term investors alike. Traders seeking systematic, data-driven exposure to high-momentum opportunities are encouraged to explore the current lineup.

What Comes Next for ARM

The most important near-term milestone for ARM is Q4 fiscal year 2026 earnings, for which the company has guided revenue of approximately $1.47 billion — a result that will either validate or test the elevated expectations now embedded in the stock. Beyond that, investors will be watching for early evidence of Meta's chip order ramp, additional customer announcements for the AGI CPU, and quarterly progress updates against the $25 billion revenue target. Broader semiconductor sector dynamics — including TSMC's production capacity, hyperscaler capex cycles, and any developments in the RISC-V ecosystem (a potential alternative to Arm architecture) — remain key risks to monitor. The expansion into chip sales also raises competitive friction with existing Arm licensees such as Qualcomm and Apple, and how those relationships evolve will be closely observed by analysts over the coming quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: ARM

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ARM in upward trend: price rose above 50-day moving average on September 17, 2026

ARM moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend. In 14 of 14 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on ARM as a result. In 41 of 49 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for ARM just turned positive on September 04, 2026. Looking at past instances where ARM's MACD turned positive, the stock continued to rise in 23 of 26 cases over the following month. The odds of a continued upward trend are 88%.

The 10-day moving average for ARM crossed bullishly above the 50-day moving average on September 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +20.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARM advanced for three days, in 172 of 200 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

ARM broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ARM entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. ARM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ARM's P/B Ratio (41.152) is very high in comparison to the industry average of (7.473). P/E Ratio (340.000) is within average values for comparable stocks, (156.350). Projected Growth (PEG Ratio) (2.736) is also within normal values, averaging (3.749). Dividend Yield (0.000) settles around the average of (0.007) among similar stocks. P/S Ratio (50.761) is also within normal values, averaging (44.558).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 207.96B. The market cap for tickers in the group ranges from 86.8K to 5.49T. NVDA holds the highest valuation in this group at 5.49T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 10%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 62%. ARM experienced the highest price growth at 36%, while MOBX experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was 24%. For the same stocks of the Industry, the average monthly volume growth was 22% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 54
Price Growth Rating: 47
SMR Rating: 72
Profit Risk Rating: 72
Seasonality Score: -19 (-100 ... +100)
View a ticker or compare two or three
ARM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Industry
N/A
Address
110 Fulbourn Road
Phone
+44 1223400400
Employees
9584
Web
https://www.arm.com
Interact to see
Advertisement
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Why Is Arm Holdings (ARM) Stock Up +10% Today?